Event: on May 20, the general office of the State Council issued a notice on printing and distributing the national health plan for the 14th five year plan (hereinafter referred to as the “plan”). The plan defines the development goals: by 2025, the health system will be more perfect, the basic medical and health system with Chinese characteristics will be gradually improved, the prevention and response ability of major epidemic diseases and public health emergencies will be significantly improved, the unique advantages of traditional Chinese medicine will be further brought into play, the innovation ability of Health Science and technology will be significantly enhanced, and the per capita life expectancy will continue to increase by about one year on the basis of 2020. Looking forward to 2035, we will establish a health system suitable for the basic realization of socialist modernization, improve the basic medical and health system with Chinese characteristics, achieve a per capita life expectancy of more than 80 years, and gradually increase the per capita health life expectancy.
Give full play to the role of traditional Chinese medicine in health services and consolidate the foundation for the high-quality development of traditional Chinese medicine.
The plan points out that in terms of health services, we should implement major projects for the revitalization and development of traditional Chinese medicine; Improve the service capacity of advantageous specialties of traditional Chinese medicine hospitals at or above the prefecture level and characteristic specialties of traditional Chinese medicine hospitals at the county level; Enrich the service connotation of traditional Chinese Medicine Museum and promote the popularization and application of appropriate technologies of traditional Chinese medicine; Explore the rehabilitation service mode conducive to giving full play to the advantages of traditional Chinese medicine; Establish and improve the working mechanism and mode of Chinese and Western medicine cooperation for national major and difficult diseases; Carry out the dissemination of traditional Chinese medicine culture and develop traditional Chinese medicine health tourism. In terms of consolidating the foundation for the development of traditional Chinese medicine, carry out the living inheritance of traditional Chinese medicine and the protection and utilization of ancient literature resources; Speed up the research and development of ancient classic prescriptions; Improve the evidence-based ability of traditional Chinese medicine and promote the scientific and technological innovation of traditional Chinese medicine; Strengthen the quality assurance of traditional Chinese medicine and build the quality standard system, monitoring system and traceability system of traditional Chinese medicine; We will promote education and teaching reform, improve the standardized training system for traditional Chinese medicine doctors and the training mechanism for general practitioners and rural doctors on traditional Chinese medicine knowledge. We believe that the plan aims to promote the inheritance, innovation and development of traditional Chinese medicine and benefit the company’s development strategy, which is in line with the policy oriented targets, such as China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) , actively expanding CHC business, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) and innovative R & D leading development.
Promote the innovative development of the pharmaceutical industry and promote the manufacturing and production of high-end medical equipment and health products. The plan points out that it is necessary to encourage the R & D, innovation and use of new drugs, accelerate the R & D and industrialization of drugs urgently needed for the treatment of major diseases, and support the R & D of high-quality generic drugs; Optimize the review process of Innovation Medical Management Co.Ltd(002173) equipment registration, carry out original technical research, and launch a batch of high-quality medical equipment integrating new technologies such as artificial intelligence; Focusing on the needs of health promotion, chronic disease management and elderly care services, focus on the development of new health products such as health management, intelligent rehabilitation aids, scientific fitness and traditional Chinese medicine health care; Promote the development of intelligent services Siasun Robot&Automation Co.Ltd(300024) and implement the promotion and application project of rehabilitation aids and intelligent aging technology, and improve the mechanism for tackling key problems in drug emergency research and development; We will deepen the reform of the review and approval system for drugs and medical devices, and speed up the review and approval of innovative drugs that meet the requirements, drugs and medical devices in urgent need, and drugs for the treatment of rare diseases. We believe that the plan is beneficial to the target of innovative new drugs and medical devices.
Improve the whole process service of eugenics. The plan points out that to improve the supporting measures related to the three child fertility policy, medical and health institutions should carry out special research on the improvement of fertility, standardize the application of human assisted reproductive technology, and provide infertility diagnosis and treatment services. We believe that the plan is beneficial to the targets of assisted reproduction such as Jinxin reproduction.
Investment rating: the general office of the State Council issued the national health plan for the 14th five year plan, which aims to improve the health system. The plan includes but is not limited to ensuring people’s health in the whole cycle, improving the quality of medical and health services, promoting the inheritance and innovative development of traditional Chinese medicine, promoting the innovative development of the pharmaceutical industry, and promoting the manufacturing and production of high-end medical equipment and health products. We believe that the plan is good for the related targets of traditional Chinese medicine, innovative medical equipment and assisted reproduction, and gives the industry a “good” rating.
Risk factors: the implementation of policies is less than expected, covid-19 epidemic risk, and R & D risk of pharmaceutical and mechanical enterprises.
